Clinical Trials Logo

Adult Primary Liver Cancer clinical trials

View clinical trials related to Adult Primary Liver Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT04390724 Recruiting - Metastatic Cancer Clinical Trials

Optimizing Y90 Therapy for Radiation Lobectomy

Start date: July 17, 2020
Phase:
Study type: Observational

HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.

NCT ID: NCT03680508 Recruiting - Clinical trials for Advanced Adult Primary Liver Cancer

TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer

Start date: December 19, 2019
Phase: Phase 2
Study type: Interventional

TSR-022 (cobolimab, TIM-3 binding antibody) and TSR-042 (dostarlimab, PD-1 binding antibody) may stop the growth of tumor cells by allowing the immune system to attack the cancer. This phase II trial is studying how well TSR-022 (cobolimab, TIM-3 binding antibody) and TSR-042 (dostarlimab, PD-1 binding antibody) work in combination in treating patients with locally advanced or metastatic liver cancer.

NCT ID: NCT01908166 Completed - Kidney Tumor Clinical Trials

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Start date: January 2014
Phase: N/A
Study type: Interventional

This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.

NCT ID: NCT00513461 Completed - Clinical trials for Hepatitis C Infection

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Start date: October 2007
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) works compared to a placebo in preventing liver cancer in patients with chronic hepatitis C infection. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of SAMe may keep cancer from forming in patients with advanced liver disease